Cardiovascular Risk Evaluation and Antiretrovirals in HIV (CREATE1)

King's College London

Status: Completed

Conditions: Cardiovascular Risk; HIV Infections

Study type: Observational

Funder types: Other

Identifiers

NCT01015092

05/Q0702/156

Details and patient eligibility

About

The purpose of the study is to determine the main factors contributing to predicted 10 year cardiovascular risk in an HIV infected cohort, and the role of anti-HIV drug use in altering this risk

Enrollment: 1,024 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Serologically proven HIV infection
• Attending general HIV outpatient clinic

Exclusion criteria

• Attending a specialist outpatient clinic which might lead to recruitment bias

Trial design

1,024 participants in 1 patient group

unselected HIV outpatient attendees

Description:

All HIV patients attending for general HIV care at 2 London Hospitals